SYNH - Syneos Health Inc Stock Price, Fair Value and News

Market Closed

SYNH Stock Valuation Analysis

Valuation

Max Portfolio %

SYNH Price Action

SYNH RSI Chart

SYNH Stock Valuation Analysis

Valuation

Max Portfolio %

SYNH Valuation

SYNH Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

SYNH Fundamentals

SYNH Revenue

SYNH Earnings

SYNH Profitability

SYNH Investor Care

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	5.4B	5.4B	0	0
2022	5.3B	5.4B	5.4B	5.4B
2021	4.5B	4.7B	5.0B	5.2B
2020	4.7B	4.6B	4.5B	4.4B
2019	4.5B	4.5B	4.6B	4.7B
2018	2.7B	3.5B	4.0B	4.4B
2017	1.4B	1.3B	1.5B	1.9B
2016	1.5B	1.6B	1.6B	1.6B
2015	1.2B	1.3B	1.3B	1.4B
2014	1.0B	1.1B	1.1B	1.2B
2013	0	0	0	995.1M
2012	0	0	0	868.6M

Get all data in R, Python etc through our Historical Stock Data APIs

About Syneos Health Inc

Syneos Health, Inc., operates as an integrated biopharmaceutical solutions company. The company operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in Phase I to IV of clinical development. This segment offers individual services, including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication; and consulting services. Its customers include companies in the biopharmaceutical, biotechnology, and medical device industries. It operates in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. The company has a strategic partnership with uMotif Limited to deliver patient-centric eClinical platform. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina.

CEO	Ms. Michelle Keefe
WEBSITE	syneoshealth.com
SECTOR	Healthcare
INDUSTRY	Diagnostics & Research
EMPLOYEES	28768